The tests are funded by social security, especially for persons whose vaccination scheme is complete or who have an order and are subject to compensation by the State.
Le Monde with AFP
In December, the wave caused by the Omicron variant resulted in a rush towards the CVIV-19 screening means, whether PCR tests, antigenic tests or self-supports. An rush that has a cost.
“We spent more than one billion euros for the tests last December with 28 million tests, and I think we will spend a little more than a billion and a half euros in the month of January, “said Monday 17 January, the Minister Delegate to the Public Accounts, Olivier Dusopt, asked about the South Radio Antenna Monday.
For the time being, a large part of the CVIV-19 screening tests are carried out “free” [no advance of costs on the part of the person tested], in particular in case of vaccination status in good standing. They are funded by social security and are subject to state compensation.
A vaccination that should cost “several billion euros” in 2022
“All tests do not have the same cost, antigenics are cheaper than PCRs in terms of public finances,” said Minister, Monday, stating: “We have always said that investments in the Medical field, tests, vaccination, were good investments “.
In the case of the cost of immunization last year, Olivier Dussopt said on Monday that the invoice had represented “just over five billion euros” and that it would cost “several billion euros in 2022 “, suggesting that it could be lower than the amount spent in 2021.
The cost of the sanitary invoice “does not prevent us from finding a more sustainable public finance trajectory,” said the minister, who affirmed the day before in the columns of the Sunday newspaper that the public deficit of France would be , Finally, “close to 7%” of the gross domestic product (GDP) in 2021, while the government was still debating 8.2% last year.